TacticScaleWhat Shandong Weigao Group Medical Polymer Does & How It Makes Money (1066.HK)
Updated October 2026 · reflects Shandong Weigao Group Medical Polymer's latest reported financials
Chinese maker of disposable medical supplies, orthopedic implants, and drug packaging. It earns most of its revenue by manufacturing and selling medical devices and consumables to hospitals, distributors, and pharmaceutical companies, and adds smaller income from medical materials, finance leasing, factoring, and consulting services.
How Shandong Weigao Group Medical Polymer makes money
It earns most of its revenue by manufacturing and selling medical devices and consumables to hospitals, distributors, and pharmaceutical companies, and adds smaller income from medical materials, finance leasing, factoring, and consulting services.
What Shandong Weigao Group Medical Polymer does
Shandong Weigao Group Medical Polymer, founded in 1988 and based in Weihai, is a broad-line Chinese medical device maker. It reports six segments: general medical devices (safe infusion, clinical nursing, perioperative, endocrine, urinary, rehabilitation and extracorporeal circulation), orthopedics (spine, joint, trauma, sports medicine, bone repair materials, spinal endoscopes, PRP and negative-pressure drainage consumables), pharma packaging (prefilled drug delivery systems and packaging consumables), interventional products (tumor, vascular and nursing interventions), blood management (blood collection and transfusion equipment), and others. The company produces its own inputs such as medical PVC granules, polymer materials, packaging bags and cartons, and also makes X-ray irradiation machines. Beyond selling products, it offers finance leasing, factoring and consulting services. It sells in China and internationally.
Products & services
- Safe infusion and clinical nursing consumables
- Prefilled drug delivery systems (prefilled syringes)
- Spine, joint and trauma orthopedic implants
- Tumor and vascular interventional products
- Whole blood collection consumables and transfusion equipment
- Medical PVC granules and polymer materials
What is Shandong Weigao Group Medical Polymer worth?
On an owner-earnings DCF, Shandong Weigao Group Medical Polymer's most-likely value is about HK$6 versus a recent price near HK$3 (40% below fair value). But TacticScale only calls a stock undervalued when the price sits below its conservative no-growth floor (~HK$3) with a margin of safety — so the honest verdict here is “Fairly priced — no edge.” Fair value earns its keep only at the extremes, not in the wide middle.
Price sits in the normal range — fair value isn't actionable here; it earns its keep only when price drops below the no-growth floor, or runs to roughly double the optimistic case.
Analysis, not advice. Fair value is a margin-of-safety estimate from a deterministic owner-earnings DCF, not a price target or recommendation. See the full breakdown →
Related companies
Shandong Weigao Blood Purification Products (603014.SS) · Beijing Wandong Medical Technology (600055.SS) · West Pharmaceutical Services (WST) · Wedge Industrial (000534.SZ) · MeHow Innovative (301363.SZ)